Eupraxia Pharmaceuticals Inc.

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, NONOF has a market cap of 194.2B. Regarding current trading prices, EPRXF is priced at $3.04, while NONOF trades at $44.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas NONOF's P/E ratio is 10.17. In terms of profitability, EPRXF's ROE is -4.83%, compared to NONOF's ROE of +0.66%. Regarding short-term risk, EPRXF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for EPRXF.Check NONOF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, CSLLY has a market cap of 66.8B. Regarding current trading prices, EPRXF is priced at $3.04, while CSLLY trades at $17.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas CSLLY's P/E ratio is 11.21. In terms of profitability, EPRXF's ROE is -4.83%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, EPRXF is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check CSLLY's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, UCBJF has a market cap of 52.4B. Regarding current trading prices, EPRXF is priced at $3.04, while UCBJF trades at $275.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas UCBJF's P/E ratio is 29.16. In terms of profitability, EPRXF's ROE is -4.83%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, EPRXF is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check UCBJF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, UCBJY has a market cap of 50.9B. Regarding current trading prices, EPRXF is priced at $3.04, while UCBJY trades at $134.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas UCBJY's P/E ratio is 28.44. In terms of profitability, EPRXF's ROE is -4.83%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, EPRXF is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check UCBJY's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, ARGNF has a market cap of 49.7B. Regarding current trading prices, EPRXF is priced at $3.04, while ARGNF trades at $803.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas ARGNF's P/E ratio is 35.71. In terms of profitability, EPRXF's ROE is -4.83%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, EPRXF is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check ARGNF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, CMXHF has a market cap of 33B. Regarding current trading prices, EPRXF is priced at $3.04, while CMXHF trades at $69.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas CMXHF's P/E ratio is 11.18. In terms of profitability, EPRXF's ROE is -4.83%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, EPRXF is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check CMXHF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, IVBXF has a market cap of 17.9B. Regarding current trading prices, EPRXF is priced at $3.04, while IVBXF trades at $10.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas IVBXF's P/E ratio is 147.14. In terms of profitability, EPRXF's ROE is -4.83%, compared to IVBXF's ROE of +0.05%. Regarding short-term risk, EPRXF is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check IVBXF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, WXIBF has a market cap of 17.4B. Regarding current trading prices, EPRXF is priced at $3.04, while WXIBF trades at $4.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas WXIBF's P/E ratio is 24.76. In terms of profitability, EPRXF's ROE is -4.83%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, EPRXF is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check WXIBF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, WXXWY has a market cap of 17.3B. Regarding current trading prices, EPRXF is priced at $3.04, while WXXWY trades at $8.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas WXXWY's P/E ratio is 24.68. In terms of profitability, EPRXF's ROE is -4.83%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, EPRXF is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check WXXWY's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, GNMSF has a market cap of 16.3B. Regarding current trading prices, EPRXF is priced at $3.04, while GNMSF trades at $265.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas GNMSF's P/E ratio is 20.16. In terms of profitability, EPRXF's ROE is -4.83%, compared to GNMSF's ROE of +0.21%. Regarding short-term risk, EPRXF is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check GNMSF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, SBHMY has a market cap of 12.7B. Regarding current trading prices, EPRXF is priced at $3.04, while SBHMY trades at $14.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas SBHMY's P/E ratio is 37.59. In terms of profitability, EPRXF's ROE is -4.83%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, EPRXF is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check SBHMY's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, SBMFF has a market cap of 12.4B. Regarding current trading prices, EPRXF is priced at $3.04, while SBMFF trades at $0.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas SBMFF's P/E ratio is 23.07. In terms of profitability, EPRXF's ROE is -4.83%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, EPRXF is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check SBMFF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, EPRXF is priced at $3.04, while BRRGF trades at $97.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, EPRXF's ROE is -4.83%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, EPRXF is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for EPRXF.Check BRRGF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, AAVXF has a market cap of 9.2B. Regarding current trading prices, EPRXF is priced at $3.04, while AAVXF trades at $115.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, EPRXF's ROE is -4.83%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, EPRXF is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check AAVXF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, EPRXF is priced at $3.04, while ODTC trades at $22,005.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas ODTC's P/E ratio is 1.07. In terms of profitability, EPRXF's ROE is -4.83%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, EPRXF is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check ODTC's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, AKBLF has a market cap of 7.8B. Regarding current trading prices, EPRXF is priced at $3.04, while AKBLF trades at $38.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas AKBLF's P/E ratio is 42.74. In terms of profitability, EPRXF's ROE is -4.83%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, EPRXF is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check AKBLF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, REGMF has a market cap of 6.8B. Regarding current trading prices, EPRXF is priced at $3.04, while REGMF trades at $12.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas REGMF's P/E ratio is 63.42. In terms of profitability, EPRXF's ROE is -4.83%, compared to REGMF's ROE of +0.42%. Regarding short-term risk, EPRXF is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check REGMF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, TRSBF has a market cap of 6.3B. Regarding current trading prices, EPRXF is priced at $3.04, while TRSBF trades at $2.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas TRSBF's P/E ratio is 4.94. In terms of profitability, EPRXF's ROE is -4.83%, compared to TRSBF's ROE of +0.38%. Regarding short-term risk, EPRXF is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check TRSBF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, EPRXF is priced at $3.04, while ABCZF trades at $22.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, EPRXF's ROE is -4.83%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, EPRXF is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check ABCZF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, SHJBF has a market cap of 4.3B. Regarding current trading prices, EPRXF is priced at $3.04, while SHJBF trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas SHJBF's P/E ratio is -25.00. In terms of profitability, EPRXF's ROE is -4.83%, compared to SHJBF's ROE of -0.11%. Regarding short-term risk, EPRXF is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check SHJBF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, ZLDPF has a market cap of 3.4B. Regarding current trading prices, EPRXF is priced at $3.04, while ZLDPF trades at $48.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas ZLDPF's P/E ratio is 3.43. In terms of profitability, EPRXF's ROE is -4.83%, compared to ZLDPF's ROE of +0.43%. Regarding short-term risk, EPRXF is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check ZLDPF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, BRCTF has a market cap of 3.4B. Regarding current trading prices, EPRXF is priced at $3.04, while BRCTF trades at $38.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas BRCTF's P/E ratio is 30.89. In terms of profitability, EPRXF's ROE is -4.83%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, EPRXF is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check BRCTF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, TLPPF has a market cap of 3.3B. Regarding current trading prices, EPRXF is priced at $3.04, while TLPPF trades at $9.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas TLPPF's P/E ratio is -487.00. In terms of profitability, EPRXF's ROE is -4.83%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, EPRXF is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check TLPPF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, INCPF has a market cap of 3.1B. Regarding current trading prices, EPRXF is priced at $3.04, while INCPF trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas INCPF's P/E ratio is 34.17. In terms of profitability, EPRXF's ROE is -4.83%, compared to INCPF's ROE of +0.10%. Regarding short-term risk, EPRXF is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check INCPF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, GNNSF has a market cap of 3.1B. Regarding current trading prices, EPRXF is priced at $3.04, while GNNSF trades at $1.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas GNNSF's P/E ratio is -5.60. In terms of profitability, EPRXF's ROE is -4.83%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, EPRXF is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check GNNSF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, EPRXF is priced at $3.04, while MPSYF trades at $73.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, EPRXF's ROE is -4.83%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, EPRXF is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check MPSYF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, BVNRY has a market cap of 2.3B. Regarding current trading prices, EPRXF is priced at $3.04, while BVNRY trades at $10.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas BVNRY's P/E ratio is 12.78. In terms of profitability, EPRXF's ROE is -4.83%, compared to BVNRY's ROE of +0.09%. Regarding short-term risk, EPRXF is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check BVNRY's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, BVNKF has a market cap of 2.3B. Regarding current trading prices, EPRXF is priced at $3.04, while BVNKF trades at $29.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas BVNKF's P/E ratio is 12.41. In terms of profitability, EPRXF's ROE is -4.83%, compared to BVNKF's ROE of +0.09%. Regarding short-term risk, EPRXF is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check BVNKF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, ASCLF has a market cap of 2.3B. Regarding current trading prices, EPRXF is priced at $3.04, while ASCLF trades at $2.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas ASCLF's P/E ratio is -42.84. In terms of profitability, EPRXF's ROE is -4.83%, compared to ASCLF's ROE of -0.19%. Regarding short-term risk, EPRXF is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check ASCLF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, MEOBF has a market cap of 2.2B. Regarding current trading prices, EPRXF is priced at $3.04, while MEOBF trades at $1.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas MEOBF's P/E ratio is -24.29. In terms of profitability, EPRXF's ROE is -4.83%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, EPRXF is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check MEOBF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, HBMHF has a market cap of 2.1B. Regarding current trading prices, EPRXF is priced at $3.04, while HBMHF trades at $2.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas HBMHF's P/E ratio is 21.00. In terms of profitability, EPRXF's ROE is -4.83%, compared to HBMHF's ROE of +0.28%. Regarding short-term risk, EPRXF is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check HBMHF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, GENSF has a market cap of 2.1B. Regarding current trading prices, EPRXF is priced at $3.04, while GENSF trades at $31.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas GENSF's P/E ratio is 32.36. In terms of profitability, EPRXF's ROE is -4.83%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, EPRXF is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check GENSF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, ASPHF has a market cap of 1.9B. Regarding current trading prices, EPRXF is priced at $3.04, while ASPHF trades at $5.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas ASPHF's P/E ratio is -9.53. In terms of profitability, EPRXF's ROE is -4.83%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, EPRXF is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check ASPHF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, EPRXF is priced at $3.04, while GLPGF trades at $28.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas GLPGF's P/E ratio is -3.50. In terms of profitability, EPRXF's ROE is -4.83%, compared to GLPGF's ROE of +0.16%. Regarding short-term risk, EPRXF is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check GLPGF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, PHMMF has a market cap of 1.8B. Regarding current trading prices, EPRXF is priced at $3.04, while PHMMF trades at $106.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas PHMMF's P/E ratio is 46.29. In terms of profitability, EPRXF's ROE is -4.83%, compared to PHMMF's ROE of +0.36%. Regarding short-term risk, EPRXF is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check PHMMF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, CSPHF has a market cap of 1.6B. Regarding current trading prices, EPRXF is priced at $3.04, while CSPHF trades at $1.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas CSPHF's P/E ratio is -20.20. In terms of profitability, EPRXF's ROE is -4.83%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, EPRXF is more volatile compared to CSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check CSPHF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, EPRXF is priced at $3.04, while BIESF trades at $32.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas BIESF's P/E ratio is -44.44. In terms of profitability, EPRXF's ROE is -4.83%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, EPRXF is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check BIESF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, ONTTF has a market cap of 1.6B. Regarding current trading prices, EPRXF is priced at $3.04, while ONTTF trades at $1.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas ONTTF's P/E ratio is -7.76. In terms of profitability, EPRXF's ROE is -4.83%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, EPRXF is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for EPRXF.Check ONTTF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, IDRSF has a market cap of 1.4B. Regarding current trading prices, EPRXF is priced at $3.04, while IDRSF trades at $5.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas IDRSF's P/E ratio is -4.36. In terms of profitability, EPRXF's ROE is -4.83%, compared to IDRSF's ROE of +0.19%. Regarding short-term risk, EPRXF is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check IDRSF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, EPRXF is priced at $3.04, while SNBIF trades at $16.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, EPRXF's ROE is -4.83%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, EPRXF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for EPRXF.Check SNBIF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, EPRXF is priced at $3.04, while MDCLF trades at $34.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, EPRXF's ROE is -4.83%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, EPRXF is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check MDCLF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, EPRXF is priced at $3.04, while NURPF trades at $8.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas NURPF's P/E ratio is 52.21. In terms of profitability, EPRXF's ROE is -4.83%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, EPRXF is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check NURPF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, CSBTF has a market cap of 975.4M. Regarding current trading prices, EPRXF is priced at $3.04, while CSBTF trades at $24.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas CSBTF's P/E ratio is 309.38. In terms of profitability, EPRXF's ROE is -4.83%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, EPRXF is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check CSBTF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, EPRXF is priced at $3.04, while BTTAY trades at $24.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, EPRXF's ROE is -4.83%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, EPRXF is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check BTTAY's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, PPTDF has a market cap of 902M. Regarding current trading prices, EPRXF is priced at $3.04, while PPTDF trades at $7.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas PPTDF's P/E ratio is -39.00. In terms of profitability, EPRXF's ROE is -4.83%, compared to PPTDF's ROE of -0.05%. Regarding short-term risk, EPRXF is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check PPTDF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, EPRXF is priced at $3.04, while TKBIF trades at $7.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas TKBIF's P/E ratio is -14.31. In terms of profitability, EPRXF's ROE is -4.83%, compared to TKBIF's ROE of N/A. Regarding short-term risk, EPRXF is less volatile compared to TKBIF. This indicates potentially lower risk in terms of short-term price fluctuations for EPRXF.Check TKBIF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, PHGUF has a market cap of 833.4M. Regarding current trading prices, EPRXF is priced at $3.04, while PHGUF trades at $1.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas PHGUF's P/E ratio is 59.00. In terms of profitability, EPRXF's ROE is -4.83%, compared to PHGUF's ROE of +0.05%. Regarding short-term risk, EPRXF is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check PHGUF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, BPMUF has a market cap of 805.6M. Regarding current trading prices, EPRXF is priced at $3.04, while BPMUF trades at $65.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas BPMUF's P/E ratio is 9.14. In terms of profitability, EPRXF's ROE is -4.83%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, EPRXF is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check BPMUF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, IVEVF has a market cap of 764.8M. Regarding current trading prices, EPRXF is priced at $3.04, while IVEVF trades at $5.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas IVEVF's P/E ratio is -2.47. In terms of profitability, EPRXF's ROE is -4.83%, compared to IVEVF's ROE of +18.92%. Regarding short-term risk, EPRXF is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check IVEVF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, VBIZF has a market cap of 622.8M. Regarding current trading prices, EPRXF is priced at $3.04, while VBIZF trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas VBIZF's P/E ratio is 29.50. In terms of profitability, EPRXF's ROE is -4.83%, compared to VBIZF's ROE of +0.06%. Regarding short-term risk, EPRXF is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check VBIZF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, SOLTF has a market cap of 613.7M. Regarding current trading prices, EPRXF is priced at $3.04, while SOLTF trades at $6.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas SOLTF's P/E ratio is -7.60. In terms of profitability, EPRXF's ROE is -4.83%, compared to SOLTF's ROE of -0.16%. Regarding short-term risk, EPRXF is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check SOLTF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, EPRXF is priced at $3.04, while CKDXF trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, EPRXF's ROE is -4.83%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, EPRXF is more volatile compared to CKDXF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check CKDXF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, AVCTF has a market cap of 538M. Regarding current trading prices, EPRXF is priced at $3.04, while AVCTF trades at $1.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas AVCTF's P/E ratio is -8.20. In terms of profitability, EPRXF's ROE is -4.83%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, EPRXF is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check AVCTF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, INRLF has a market cap of 489.3M. Regarding current trading prices, EPRXF is priced at $3.04, while INRLF trades at $2.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas INRLF's P/E ratio is -2.74. In terms of profitability, EPRXF's ROE is -4.83%, compared to INRLF's ROE of -1.06%. Regarding short-term risk, EPRXF is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check INRLF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, CYDY has a market cap of 478.1M. Regarding current trading prices, EPRXF is priced at $3.04, while CYDY trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas CYDY's P/E ratio is -8.75. In terms of profitability, EPRXF's ROE is -4.83%, compared to CYDY's ROE of +0.37%. Regarding short-term risk, EPRXF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for EPRXF.Check CYDY's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, GNFTF has a market cap of 474.3M. Regarding current trading prices, EPRXF is priced at $3.04, while GNFTF trades at $9.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas GNFTF's P/E ratio is -4.69. In terms of profitability, EPRXF's ROE is -4.83%, compared to GNFTF's ROE of -5.96%. Regarding short-term risk, EPRXF is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for EPRXF.Check GNFTF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, EPRXF is priced at $3.04, while RAONF trades at $2.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas RAONF's P/E ratio is -43.33. In terms of profitability, EPRXF's ROE is -4.83%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, EPRXF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for EPRXF.Check RAONF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, EPRXF is priced at $3.04, while GNFTY trades at $8.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, EPRXF's ROE is -4.83%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, EPRXF is more volatile compared to GNFTY. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check GNFTY's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, BOVNF has a market cap of 436.3M. Regarding current trading prices, EPRXF is priced at $3.04, while BOVNF trades at $6.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas BOVNF's P/E ratio is -14.11. In terms of profitability, EPRXF's ROE is -4.83%, compared to BOVNF's ROE of -0.54%. Regarding short-term risk, EPRXF is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for EPRXF.Check BOVNF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, EPRXF is priced at $3.04, while TBGNF trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, EPRXF's ROE is -4.83%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, EPRXF is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check TBGNF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, NWPHF has a market cap of 416.1M. Regarding current trading prices, EPRXF is priced at $3.04, while NWPHF trades at $20.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas NWPHF's P/E ratio is -25.97. In terms of profitability, EPRXF's ROE is -4.83%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, EPRXF is less volatile compared to NWPHF. This indicates potentially lower risk in terms of short-term price fluctuations for EPRXF.Check NWPHF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, PTCHF has a market cap of 411.4M. Regarding current trading prices, EPRXF is priced at $3.04, while PTCHF trades at $1.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas PTCHF's P/E ratio is -3.67. In terms of profitability, EPRXF's ROE is -4.83%, compared to PTCHF's ROE of -0.32%. Regarding short-term risk, EPRXF is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check PTCHF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, NWBO has a market cap of 401.7M. Regarding current trading prices, EPRXF is priced at $3.04, while NWBO trades at $0.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas NWBO's P/E ratio is -6.25. In terms of profitability, EPRXF's ROE is -4.83%, compared to NWBO's ROE of +0.63%. Regarding short-term risk, EPRXF is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check NWBO's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, CLVLY has a market cap of 344.8M. Regarding current trading prices, EPRXF is priced at $3.04, while CLVLY trades at $6.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas CLVLY's P/E ratio is 14.55. In terms of profitability, EPRXF's ROE is -4.83%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, EPRXF is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check CLVLY's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, CLVLF has a market cap of 343.8M. Regarding current trading prices, EPRXF is priced at $3.04, while CLVLF trades at $6.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas CLVLF's P/E ratio is 14.51. In terms of profitability, EPRXF's ROE is -4.83%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, EPRXF is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check CLVLF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, SPHDF has a market cap of 337.7M. Regarding current trading prices, EPRXF is priced at $3.04, while SPHDF trades at $23.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas SPHDF's P/E ratio is -4.80. In terms of profitability, EPRXF's ROE is -4.83%, compared to SPHDF's ROE of +6.85%. Regarding short-term risk, EPRXF is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check SPHDF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, SLNCF has a market cap of 334.4M. Regarding current trading prices, EPRXF is priced at $3.04, while SLNCF trades at $2.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas SLNCF's P/E ratio is -4.37. In terms of profitability, EPRXF's ROE is -4.83%, compared to SLNCF's ROE of -1.15%. Regarding short-term risk, EPRXF is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check SLNCF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, SCNLF has a market cap of 325.2M. Regarding current trading prices, EPRXF is priced at $3.04, while SCNLF trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas SCNLF's P/E ratio is -31.34. In terms of profitability, EPRXF's ROE is -4.83%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, EPRXF is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check SCNLF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, EPRXF is priced at $3.04, while NGENF trades at $3.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas NGENF's P/E ratio is -15.19. In terms of profitability, EPRXF's ROE is -4.83%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, EPRXF is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check NGENF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, EPRXF is priced at $3.04, while FGHQF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, EPRXF's ROE is -4.83%, compared to FGHQF's ROE of +0.02%. Regarding short-term risk, EPRXF is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check FGHQF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, HLOSF has a market cap of 290.7M. Regarding current trading prices, EPRXF is priced at $3.04, while HLOSF trades at $2.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas HLOSF's P/E ratio is -15.88. In terms of profitability, EPRXF's ROE is -4.83%, compared to HLOSF's ROE of -0.75%. Regarding short-term risk, EPRXF is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check HLOSF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, EPRXF is priced at $3.04, while PBBIF trades at $24.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, EPRXF's ROE is -4.83%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, EPRXF is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check PBBIF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, EPRXF is priced at $3.04, while ORPOF trades at $11.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, EPRXF's ROE is -4.83%, compared to ORPOF's ROE of N/A. Regarding short-term risk, EPRXF is more volatile compared to ORPOF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check ORPOF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, EPRXF is priced at $3.04, while HNSBF trades at $2.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas HNSBF's P/E ratio is -3.41. In terms of profitability, EPRXF's ROE is -4.83%, compared to HNSBF's ROE of +2.02%. Regarding short-term risk, EPRXF is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check HNSBF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, OPORF has a market cap of 240.9M. Regarding current trading prices, EPRXF is priced at $3.04, while OPORF trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas OPORF's P/E ratio is 35.00. In terms of profitability, EPRXF's ROE is -4.83%, compared to OPORF's ROE of -0.15%. Regarding short-term risk, EPRXF is more volatile compared to OPORF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check OPORF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, ORYZF has a market cap of 234.9M. Regarding current trading prices, EPRXF is priced at $3.04, while ORYZF trades at $3.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas ORYZF's P/E ratio is -75.75. In terms of profitability, EPRXF's ROE is -4.83%, compared to ORYZF's ROE of -0.02%. Regarding short-term risk, EPRXF is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check ORYZF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, CMVLF has a market cap of 222.8M. Regarding current trading prices, EPRXF is priced at $3.04, while CMVLF trades at $3.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas CMVLF's P/E ratio is -4.60. In terms of profitability, EPRXF's ROE is -4.83%, compared to CMVLF's ROE of -0.81%. Regarding short-term risk, EPRXF is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check CMVLF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, IPHYF has a market cap of 211.1M. Regarding current trading prices, EPRXF is priced at $3.04, while IPHYF trades at $2.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas IPHYF's P/E ratio is -3.52. In terms of profitability, EPRXF's ROE is -4.83%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, EPRXF is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check IPHYF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, EPRXF is priced at $3.04, while FPHAF trades at $3.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, EPRXF's ROE is -4.83%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, EPRXF is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check FPHAF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, SPHRY has a market cap of 192.8M. Regarding current trading prices, EPRXF is priced at $3.04, while SPHRY trades at $4.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas SPHRY's P/E ratio is -76.33. In terms of profitability, EPRXF's ROE is -4.83%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, EPRXF is more volatile compared to SPHRY. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check SPHRY's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, PHCUF has a market cap of 186.2M. Regarding current trading prices, EPRXF is priced at $3.04, while PHCUF trades at $7.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas PHCUF's P/E ratio is 20.59. In terms of profitability, EPRXF's ROE is -4.83%, compared to PHCUF's ROE of +0.17%. Regarding short-term risk, EPRXF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check PHCUF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, SPHRF has a market cap of 183.7M. Regarding current trading prices, EPRXF is priced at $3.04, while SPHRF trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas SPHRF's P/E ratio is -43.63. In terms of profitability, EPRXF's ROE is -4.83%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, EPRXF is more volatile compared to SPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check SPHRF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, RECEF has a market cap of 182.6M. Regarding current trading prices, EPRXF is priced at $3.04, while RECEF trades at $0.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas RECEF's P/E ratio is -8.33. In terms of profitability, EPRXF's ROE is -4.83%, compared to RECEF's ROE of +2.79%. Regarding short-term risk, EPRXF is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for EPRXF.Check RECEF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, EPRXF is priced at $3.04, while ADOCY trades at $11.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, EPRXF's ROE is -4.83%, compared to ADOCY's ROE of +8.60%. Regarding short-term risk, EPRXF is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check ADOCY's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, KNTPF has a market cap of 164.4M. Regarding current trading prices, EPRXF is priced at $3.04, while KNTPF trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas KNTPF's P/E ratio is -5.84. In terms of profitability, EPRXF's ROE is -4.83%, compared to KNTPF's ROE of -0.63%. Regarding short-term risk, EPRXF is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check KNTPF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, BBIXF has a market cap of 151.8M. Regarding current trading prices, EPRXF is priced at $3.04, while BBIXF trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas BBIXF's P/E ratio is -13.00. In terms of profitability, EPRXF's ROE is -4.83%, compared to BBIXF's ROE of -15.41%. Regarding short-term risk, EPRXF is less volatile compared to BBIXF. This indicates potentially lower risk in terms of short-term price fluctuations for EPRXF.Check BBIXF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, EPRXF is priced at $3.04, while AMGXF trades at $0.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, EPRXF's ROE is -4.83%, compared to AMGXF's ROE of -0.71%. Regarding short-term risk, EPRXF is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check AMGXF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, EPRXF is priced at $3.04, while BRIBF trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas BRIBF's P/E ratio is -3.76. In terms of profitability, EPRXF's ROE is -4.83%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, EPRXF is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check BRIBF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, HBPCF has a market cap of 130.6M. Regarding current trading prices, EPRXF is priced at $3.04, while HBPCF trades at $1.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas HBPCF's P/E ratio is -42.75. In terms of profitability, EPRXF's ROE is -4.83%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, EPRXF is more volatile compared to HBPCF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check HBPCF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, EPRXF is priced at $3.04, while AAPGV trades at $17.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas AAPGV's P/E ratio is N/A. In terms of profitability, EPRXF's ROE is -4.83%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, EPRXF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for EPRXF.Check AAPGV's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, TRGNF has a market cap of 122.6M. Regarding current trading prices, EPRXF is priced at $3.04, while TRGNF trades at $0.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas TRGNF's P/E ratio is -2.83. In terms of profitability, EPRXF's ROE is -4.83%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, EPRXF is more volatile compared to TRGNF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check TRGNF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, EPRXF is priced at $3.04, while PSTTF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, EPRXF's ROE is -4.83%, compared to PSTTF's ROE of N/A. Regarding short-term risk, EPRXF is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check PSTTF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, JWCTF has a market cap of 116.7M. Regarding current trading prices, EPRXF is priced at $3.04, while JWCTF trades at $0.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas JWCTF's P/E ratio is -1.40. In terms of profitability, EPRXF's ROE is -4.83%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, EPRXF is more volatile compared to JWCTF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check JWCTF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, ATGGF has a market cap of 113.4M. Regarding current trading prices, EPRXF is priced at $3.04, while ATGGF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas ATGGF's P/E ratio is N/A. In terms of profitability, EPRXF's ROE is -4.83%, compared to ATGGF's ROE of -1.34%. Regarding short-term risk, EPRXF is more volatile compared to ATGGF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check ATGGF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, POLBF has a market cap of 106.5M. Regarding current trading prices, EPRXF is priced at $3.04, while POLBF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas POLBF's P/E ratio is -15.10. In terms of profitability, EPRXF's ROE is -4.83%, compared to POLBF's ROE of -0.55%. Regarding short-term risk, EPRXF is less volatile compared to POLBF. This indicates potentially lower risk in terms of short-term price fluctuations for EPRXF.Check POLBF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, EPRXF is priced at $3.04, while ADOIF trades at $8.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, EPRXF's ROE is -4.83%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, EPRXF is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check ADOIF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, MSCLF has a market cap of 96.6M. Regarding current trading prices, EPRXF is priced at $3.04, while MSCLF trades at $6.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas MSCLF's P/E ratio is 2.43. In terms of profitability, EPRXF's ROE is -4.83%, compared to MSCLF's ROE of -0.70%. Regarding short-term risk, EPRXF is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for EPRXF.Check MSCLF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, MLLCF has a market cap of 95.4M. Regarding current trading prices, EPRXF is priced at $3.04, while MLLCF trades at $2.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas MLLCF's P/E ratio is -1.29. In terms of profitability, EPRXF's ROE is -4.83%, compared to MLLCF's ROE of -0.66%. Regarding short-term risk, EPRXF is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for EPRXF.Check MLLCF's competition here

EPRXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPRXF stands at 108.3M. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, EPRXF is priced at $3.04, while MCURF trades at $0.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPRXF currently has a P/E ratio of -2.69, whereas MCURF's P/E ratio is -16.90. In terms of profitability, EPRXF's ROE is -4.83%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, EPRXF is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for EPRXF.Check MCURF's competition here